A functional T-cell receptor signaling pathway is required for p95vav activity

Stimulation of the T-cell antigen receptor (TCR) induces activation of multiple tyrosine kinases, resulting in phosphorylation of numerous intracellular substrates. One substrate is p95vav, which is expressed exclusively in hematopoietic and trophoblast cells. It contains a number of structural motifs, including Src homology 2, Src homology 3, and pleckstrin homology domains and a putative guanine nucleotide exchange domain. The role of p95vav in TCR-mediated signaling processes is unclear. Here, we show that overexpression of p95vav alone in Jurkat T cells leads to activation of the nuclear factors, including NFAT, involved in interleukin-2 expression. Furthermore, p95vav synergizes with TCR stimulation in inducing NFAT- and interleukin-2-dependent transcription. In contrast, NFAT activation by a G-protein-coupled receptor is not modulated by p95vav overexpression, suggesting that the effect is specific to the TCR signaling pathways. Although removal of the first 67 amino acids of p95vav activates its transforming potential in NIH 3T3 cells, this region appears to be required for its function in T cells. We further demonstrate that the p95vav-induced NFAT activation is not mimicked by Ras activation, though its function is dependent upon Ras and Raf. Furthermore, the activating function of p95vav is blocked by FK506, suggesting that its activity also depends on calcineurin. To further dissect p95vav involvement in TCR signaling, we analyzed various Jurkat mutants deficient in TCR signaling function or TCR expression and showed that an intact TCR signaling pathway is required for p95vav to function. However, overexpression of p95vav does not appear to influence TCR-induced protein tyrosine phosphorylation or increases in cytoplasmic free calcium. Taken together, our data suggest that p95vav plays an important role at an yet unidentified proximal position in the TCR signaling cascade.

[1]  M. Barbacid,et al.  Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.

[2]  F. Alt,et al.  Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.

[3]  K. Rajewsky,et al.  Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.

[4]  G. Dreyfuss,et al.  Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteins , 1995, Molecular and cellular biology.

[5]  S. Shoelson,et al.  Interaction of Shc with Grb2 regulates association of Grb2 with mSOS , 1995, Molecular and cellular biology.

[6]  M. Barbacid,et al.  The vav proto‐oncogene is required early in embryogenesis but not for hematopoietic development in vitro. , 1995, The EMBO journal.

[7]  J. Norman,et al.  The small GTPases Rac and Rho as regulators of secretion in mast cells , 1995, Current Biology.

[8]  A. Weiss,et al.  The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. , 1994, The Journal of biological chemistry.

[9]  C. Der,et al.  Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras , 1994, Molecular and cellular biology.

[10]  R. Bram,et al.  Calcium signalling in T cells stimulated by a cyclophilin B-binding protein , 1994, Nature.

[11]  O. Hobert,et al.  Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. , 1994, The Journal of biological chemistry.

[12]  M. Barbacid,et al.  Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. , 1994, Oncogene.

[13]  J. Schlessinger,et al.  GRB2 and phospholipase C-gamma 1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation , 1994, Molecular and cellular biology.

[14]  A. Wittinghofer,et al.  Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides , 1994, Molecular and cellular biology.

[15]  A. Nel,et al.  The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. , 1994, The Journal of biological chemistry.

[16]  M. Barbacid,et al.  Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products. , 1994, The Journal of biological chemistry.

[17]  A. Altman,et al.  Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells. , 1994, Journal of immunology.

[18]  A. Weiss,et al.  Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. , 1994, Science.

[19]  A. Wittinghofer,et al.  Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein , 1994, Molecular and cellular biology.

[20]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[21]  S. Aaronson,et al.  Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. , 1994, The Journal of biological chemistry.

[22]  G. Won,et al.  Zinc Finger Domains and Phorbol Ester Pharmacophore , 1994 .

[23]  Mark S. Boguski,et al.  Proteins regulating Ras and its relatives , 1993, Nature.

[24]  D. Cantrell,et al.  p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells , 1993, The Journal of experimental medicine.

[25]  L. Davis,et al.  Raf‐1 is required for T cell IL2 production. , 1993, The EMBO journal.

[26]  J. Thompson,et al.  The PH domain: a common piece in the structural patchwork of signalling proteins. , 1993, Trends in biochemical sciences.

[27]  W. Farrar,et al.  Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. , 1993, The Biochemical journal.

[28]  J. Schlessinger,et al.  How receptor tyrosine kinases activate Ras. , 1993, Trends in biochemical sciences.

[29]  A. Altman,et al.  Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. , 1993, Science.

[30]  A. Weiss,et al.  CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. , 1993, The EMBO journal.

[31]  J. Downward,et al.  p21ras mediates control of IL‐2 gene promoter function in T cell activation. , 1992, The EMBO journal.

[32]  Arthur Weiss,et al.  ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain , 1992, Cell.

[33]  Arthur Weiss,et al.  Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor , 1992, Cell.

[34]  Anne J. Ridley,et al.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.

[35]  Anne J. Ridley,et al.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors , 1992, Cell.

[36]  Amos Bairoch,et al.  Proto-vav and gene expression , 1992, Nature.

[37]  J. Downward,et al.  Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells , 1992, Molecular and cellular biology.

[38]  G. Crabtree,et al.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation , 1992, Nature.

[39]  E. A. O'neill,et al.  FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin , 1992, Nature.

[40]  M. Barbacid,et al.  Tyrosine Phosphorylation of the vav Proto-Oncogene Product in Activated B Cells , 1992, Science.

[41]  C. Klee,et al.  Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Lints,et al.  The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.

[43]  M. Amiot,et al.  Sequence requirements for induction of cytolysis by the T cell antigen Fc receptor ζ chain , 1992, Cell.

[44]  M. Barbacid,et al.  Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates , 1992, Nature.

[45]  D. Birnbaum,et al.  The products of the mcf-2 and vav proto-oncogenes and of the yeast gene cdc-24 share sequence similarities. , 1992, Oncogene.

[46]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[47]  L. Bockenstedt,et al.  Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number. , 1991, Journal of immunology.

[48]  J. Cleveland,et al.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential , 1991, Molecular and cellular biology.

[49]  R. Stancou,et al.  A hemopoietic specific gene encoding a small GTP binding protein is overexpressed during T cell activation. , 1991, Biochemical and biophysical research communications.

[50]  A. Weiss,et al.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Arthur Weiss,et al.  The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways , 1991, Cell.

[52]  M. Barbacid,et al.  Mechanism of activation of the vav protooncogene. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[53]  G. Carpenter,et al.  Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. , 1990, Science.

[54]  A. Weiss,et al.  Stimulation of the phosphatidyl-inositol pathway can induce T-cell activation , 1990, Nature.

[55]  G. Schieven,et al.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Nagata,et al.  pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.

[57]  P. Warne,et al.  Stimulation of p21ras upon T-cell activation , 1990, Nature.

[58]  A. Weiss,et al.  Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway , 1990, Nature.

[59]  A. Weiss,et al.  Stimulation of the phosphatidylinositol pathway can induce T-cell activation. , 1990, Nature.

[60]  G. Crabtree,et al.  Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. , 1989, Science.

[61]  M. Goldsmith,et al.  Function of a heterologous muscarinic receptor in T cell antigen receptor signal transduction mutants. , 1989, The Journal of biological chemistry.

[62]  M. Barbacid,et al.  vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. , 1989, The EMBO journal.

[63]  M. Goldsmith,et al.  At least two non-antigen-binding molecules are required for signal transduction by the T-cell antigen receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  G. Crabtree,et al.  Characterization of antigen receptor response elements within the interleukin-2 enhancer , 1988, Molecular and cellular biology.

[65]  M. Goldsmith,et al.  Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[66]  T. Mak,et al.  Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer , 1985, Nature.

[67]  A. Weiss,et al.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line , 1984, The Journal of experimental medicine.